Although reported in typical surface-skimming Business Insider tabloid/SEO-max style, Noah Plaue’s account of anandamide’s potential for humans really is quite interesting…
Promising research shows how to increase a chemical within us that counteracts fear.
Scientists from Duke University and the National Institute of Health studied an endocannabinoid chemical, called anandamide, that is secreted naturally in humans and causes bliss while reducing anxiety. The chemical works similarly to marijuana.
By blocking an enzyme called FAAH that breaks down this chemical, the researchers successfully reduced fear in mice and believe that the same thing could very well work for humans.
As the paper notes, the potential for curing anxiety and stress disorders is truly exciting:
Our mouse data suggest that, by preventing FAAH-mediated degradation, augmenting anandamide in the basolateral amygdala may boost on-demand recruitment of endocannabinoids to facilitate the extinction of traumatic fear memories. Further we report an association between a putative loss-of-function human FAAH gene variant, an amygdala fear-plasticity endophenotype, and reduced trait stress reactivity. The collective results of our study support the endocannabinoid system and FAAH as a key signaling mechanism regulating fear plasticity that is conserved across mouse and man…
[continues at Business Insider]
Latest posts by majestic (see all)
- Creatives, designers and drugs: what are they on, and why? - May 16, 2016
- Why We Keep Dreaming of Little Green Men - May 15, 2016
- What Is The Value Of Conspiracy? - May 13, 2016